Lucie Kolatorova

Dr. Lucie Kolatorova

Institute of Endocrinology, Prague, Praha, Hlavní Město, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LKLucie Kolatorova
Lucie Kolatorova
Jana VitkuJana Vitku
Jana Vitku
JSJosef Suchopar
Josef Suchopar
Martin HillMartin Hill
Martin Hill
APAntonin Parizek
Antonin Parizek
Progesterone is a steroid hormone traditionally linked with female fertility and pregnancy. In current reproductive medicine, progesterone and its analogues play crucial roles. While the discovery of its effects has a long history, over recent decades, various novel actions of this interesting steroid have been documented, of which its neuro- and immunoprotective activities are the most widely discussed. Discoveries of the novel biological activities of progesterone have also driven research and development in the field of progesterone analogues used in human medicine. Progestogen treatment has traditionally and predominately been used in maintaining pregnancy, the prevention of preterm labor, various gynecological pathologies, and in lowering the negative effects of menopause. However, there are also various other medical fields where progesterone and its analogues could find application in the future. The aim of this work is to show the mechanisms of action of progesterone and its metabolites, the physiological and pharmacological actions of progesterone and its synthetic analogues in human medicine, as well as the impacts of its production and use on the environment.

1 May 2018 in Environmental Research
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
Jana VitkuJana Vitku
Jana Vitku
RHRichard Hampl
Richard Hampl
KAKarolina Adamcova
Karolina Adamcova
TSTereza Skodova
Tereza Skodova
MDMichaela Duskova
Michaela Duskova

1 November 2017 in Talanta
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
TCTereza Chlupacova
Tereza Chlupacova
Jana VitkuJana Vitku
Jana Vitku
MVMartin Vlk
Martin Vlk
JHJiri Heracek
Jiri Heracek
RHRichard Hampl
Richard Hampl

12 November 2018 in Physiological Research
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
MSM. Sramkova
M. Sramkova
JVJ. Vitku
J. Vitku
JVJ. Vcelak
J. Vcelak
OLO. Lischkova
O. Lischkova
MDM. Duskova
M. Duskova
Parabens are a group of chemicals used as preservatives in the food, cosmetic and pharmaceutical industries. They are known to possess estrogenic effects, and therefore have been classified as endocrine disruptors. In addition to the classical endocrine organs, other tissues have endocrine activity, including adipose tissue. Several chemicals are known to cause obesogenic effects, and parabens are currently being studied in this context. The aim of this study was to investigate the possible connections of paraben exposure and obesity. Blood plasma from 27 healthy women was collected during their menstrual cycle. Basal anthropometric measures, levels of parabens (methylparaben, ethylparaben and propylparaben), adipokines (adiponectin, adipsin, leptin, resistin and visfatin) and hormones affecting energy balance and metabolic health (c-peptide, ghreline, GIP, GLP-1, glucagon, insulin, PAI-1) were measured. A Kolmogorov-Smirnov test showed higher methylparaben and propylparaben levels in women with BMI 25-34.9 compared to those with BMI 18.5-24.9. Plasma levels of methylparaben as well as the sum of parabens were positively associated with the plasma adipsin levels. Negative associations for methylparaben were found for glucagon, leptin and PAI-1. In accordance with other experimental studies we observed important associations of methylparaben and hormones affecting energy balance and metabolic health, indicating its obesogenic potential.

12 November 2018 in Physiological Research
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
OLO. Lapčík
O. Lapčík
LSL. Stárka
L. Stárka
The microflora of the digestive tract is composed of a unique set of bacteria, yeasts, viruses and other microorganisms, generally known as the microbiome. The microbiome exhibits considerable inter-individual variability, with up to two-thirds of the microflora differing between individuals. Because of this, the variable intestinal microflora is responsible for many differences in metabolic, hormonal and immunological processes in humans and animals. Significant differences have been observed in the metabolism of phytoestrogens, naturally occurring substances that possess estrogenic or anti-estrogenic activity. These substances occur predominately in legumes, especially in soy and many soy products. Because of their effects, phytoestrogens are used as an alternative therapy for menopausal disorders and benign prostate hyperplasia. In connection with the worldwide expansion of soy products as part of healthy lifestyles including vegetarianism and veganism, phytoestrogens have become a regular part of everyday life. The activity of phytoestrogens is strongly dependent on the microbiome. Their metabolites have stronger estrogenic activity than the natural substances themselves, and because of the variability in microbiomes, there are large differences in the effects of phytoestrogens among individuals.

16 September 2017 in Physiological Research
Verified
Journal Article
Closed access
LKLucie Kolatorova
Lucie Kolatorova
MDM. Duskova
M. Duskova
JVJ. Vitku
J. Vitku
LSL. Starka
L. Starka
In modern societies, living organisms are exposed daily to multiform pollution from industrial chemical products. Some of these substances have been shown to affect the endocrine system, and have been termed endocrine disruptors (EDs). Bisphenol A (BPA), which can leach from plastics, and parabens, used in cosmetic products, are among the most well-studied. Prenatal development is a vulnerable phase of human life, and disruptions during this period may have lifelong consequences. Since EDs are known to cross the placental barrier and BPA may accumulate in the fetus, “BPA-free” products have been introduced to the market. However, such products often contain alternative bisphenols (e.g. BPS, BPF) that have not yet been extensively examined or regulated. Moreover, alternative bisphenols often occur together with BPA. The human organism is thus exposed to a mixture of EDs, some of which can have additive or synergic effects. Recent findings have also shown that paraben exposure can alter bisphenol pharmacokinetics. Taking into account the widespread occurrence of various EDs and the potential multiplicity of their effects, doses of EDs currently considered safe may not actually be as safe as they appear, especially during pregnancy.